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Background: Cancer is both a systemic and a genetic disease. The pathogenesis of cancer might be related to
dampened immunity. Host immunity recognizes nascent malignant cells – a process referred to as immune
surveillance. Augmenting immune surveillance and suppressing immune escape are crucial in tumor
immunotherapy.
Methods: A recombinant plasmid capable of co-expressing granulocyte-macrophage colony- stimulating factor
(GM-SCF), interleukin-21 (IL-21), and retinoic acid early transcription factor-1 (Rae-1) was constructed, and its effects
determined in a mouse model of subcutaneous liver cancer. Serum specimens were assayed for IL-2 and INF-γ by
ELISA. Liver cancer specimens were isolated for Rae-1 expression by RT-PCR and Western blot, and splenocytes were
analyzed by flow cytometry.
Results: The recombinant plasmid inhibited the growth of liver cancer and prolonged survival of tumor-loaded
mice. Activation of host immunity might have contributed to this effect by promoting increased numbers and
cytotoxicity of natural killer (NK) cells and cytotoxic T lymphocytes (CTL) following expression of GM-SCF, IL-21, and
Rae-1. By contrast, the frequency of regulatory T cells was decreased, Consequently, activated CTL and NK cells
enhanced their secretion of INF-γ, which promoted cytotoxicity of NK cells and CTL. Moreover, active CTL showed
dramatic secretion of IL-2, which stimulates CTL. The recombinant expression plasmid also augmented Rae-1
expression by liver cancer cells. Rae-1 receptor expressing CTL and NK cells removed liver cancer.
Conclusions: The recombinant expression plasmid inhibited liver cancer by a mechanism that involved activation
of cell-mediated immunity and Rae-1 in liver cancer.
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In the 1950s, Burnet proposed that the immune system
could recognize nascent malignant transformed cells in a
process known today as immune surveillance [1]. Anti-
tumor immunity to aberrant self-antigen (tumor antigen)
is prioritized in cellular immunity, and requires the inter-
play of a variety of accessory and major effector cells in-
cluding CD8+ and CD4+ T cells [2,3]. When tumor cells
fail to express an antigenic epitope, defects might occur
in antigen processing, modulation, or tumor antigen
loss. There might also be a lack of major histocompati-
bility complex class I (MHC- I) expression, functional
co-stimulatory molecule expression, inhibition of tumor
cell expression, and tumor cell expression of apoptotic
regulatory ligands. In addition, there could be general
immunodeficiency and immunosuppression of natural
killer (NK) cell and cytotoxic T cell (CTL) activity. Col-
lectively. each of these pathways could promote immune
escape of the tumor target [4-6]. Therefore, cancer cells
attempt to use multiple mechanisms to escape recogni-
tion by and attack by host immunity to promote their
survival and proliferative capability. However, immune
escape can be avoided in one of two ways. Firstly host
immunity could be stimulated, especially in the context
of anti-tumor CTL and NK cells. Secondly the expression
of antibodies or ligands that are recognized by host im-
munity in cancer cells might be augmented, and examples
of this include natural killer group 2D (NKG2D).
NKG2D is a C-type lectin-like activating receptor that
is present on the surface of NK cells with a stress-
inducible ligand of MHC- I class molecules A/B (MIC
A/B) [7]. The retinoic acid early transcription factor-1
(Rae-1) is one of the most frequently studied mouse
NKG2D ligands. Rae-1 is detected in many mouse can-
cer cells. Similar to MICA and MICB ligands of NKG2D
in the human immune system, Rae-1 is highly expressed
under stressful environments (e.g., in response to heat
shock, ultraviolet light, virus infection, malignant trans-
formation, and exposure to carcinogenic substances).
The affinity of Rae-1 for NKG2D is tens or hundreds of
times greater than that of the killer inhibitory receptor
(KIR) [8]. Rae-1 is not expressed in normal cells but is
restricted to expression by epithelial cancer cells. Expres-
sion of Rae-1 is combined with NKG2D and mediated by
the DAP10 pathway (the “self-induction hypothesis”),
making cancer cell expression of Rae-1 easily identified by
immune cells and hence removal of cancer cells that ex-
press it [9]. Thus NK and CD8 +T cells are capable of re-
moving cancer cells that highly express NKG2D ligands
[10]. In vitro experiments showed that induced expression
of NKG2D ligands following transfection of cancer cells
and antibody blocking significantly enhance tumor cell
susceptibility to NK cells. Perhaps of greater relevance is
the observation that subcutaneous injection of cancer cellscontaining the transfected NKG2D gene in mice induces
potent tumoricidal immune responses and significant
dampening of tumor cell growth [10]. Consequently, im-
mune cells easily identify tumor cells that highly express
Rae-1.
Others have shown that gene expression of both GM-
CSF and IL-21 can significantly inhibit tumors and acti-
vate host immunity including CTL and NK cell activation
[11,12]. Previously, we studied recombinant plasmids that
expressed both GM-CSF and IL-21 in a mouse model of
orthotopic liver cancer by intravenous tail vein injection
[13]. This construct markedly blocked the growth of tu-
mors and enhanced both NK cell and CTL activity.
The current study focuses on stimulating either cell-
mediated immune activation including CTL and NK
cells [14], or enhancing the expression of molecules like
Rae-1 that are expressed by tumor cells and subse-
quently identified by host immunity [15]. Few reports
have shown the effects of attempting to simultaneously
increase immune activation and the molecules identified
by immune surveying cells. In this study, we propose an
immune escape inhibitory system that is based on the




Methyl Thiazolyl Tetrazolium (MTT) was obtained from
Sigma Ltd, Shanghai, China. Plasmid maxi preparation
kits were obtained from Promega (Beijing) Biotech Co.,
Ltd., Beijing, China. Interferon (IFN-γ), interleukin-2
(IL-2), and enzyme-linked immunosorbent assay (ELISA)
kits were obtained from Santa Cruz Biotechnology,
Santa Cruz, CA, USA. Fluorescent-labeled antibodies of
fluorescein isothiocyanate (FITC)-anti-mouse CD3, PE-
anti-mouse CD4, PE-anti mouse CD8, FITC-anti-mouse
CD25, Alexa 647-anti mouse Foxp3, FITC-anti-mouse
CD11b, and PE-anti-mouse CD27 were provided by BD
Bioscience, San Jose, CA, USA.
Mice and cell-lines
Balb/c mice (male, 7 wk old, weighing 20 g, and specific
pathogen free (SPF)) were obtained from the Animal
Center of Fudang University (Shanghai, China). Hepatic
cancer cells (H22) were provided by the China Center
for Type Culture Collection (CCTCC, Wuhan, China).
The target cell-line YAC-1 of natural killer (NK) cell ori-
gin was routinely cultured in the immunology laboratory
of Shanghai Fudan University. The selected culture
medium was RPMI 1640 and was obtained from the
Sigma Chemical Company. The ethics committee of
Shanghai Zhoupu Hospital (Shanghai, China) and Fudan
University approved the mouse model experiments de-
scribed in this report.
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pGM-CSF-GFP -IRES-IL-21-Rae-1
The genes for both GM-CSF and IL-21 were obtained
from the spleens of mice. Rae-1 and GFP were chem-
ically synthesized. The polymerase chain reaction (PCR)
primers were designed and synthesized according to the
genetic coding sequence (CDS) for both GM-CSF and
IL-21 (Table 1). The enzyme cleavage sites targeted by
Xhol and EcoRI were added to the 5′ and 3′ ends of the
GM-CSF gene, respectively. EcoRI and MluI cleavage
sites were added to the 5′ and 3′ ends of the GFP gene,
respectively. Xba1 and Sal1 cleavage sites were added to
the 5′ and 3′ end of the Rae-1 gene, respectively. Sal1
and Not1 cleavage sites were added to the 5′ and 3′
ends of the IL-21 gene, respectively. GFP segmentation
was connected with a destination vector pIRES, forming
a plasmid pGFP-IRES, which was added to the GM-CSF
gene to form a vector referred to as pGM-CSF-GFP-
IRES, followed by insertion of the PCR products of the
Rae-1 gene to obtain a new vector referred to as pGM-
CSF-GFP-IRES-Rae-1. The IL-21 digested segments were
inserted to form the pGM-CSF-GFP-IRES-Rae-1 expres-
sion construct, to form a eukaryotic expression vector
referred to as pGM-CSF-GFP-IRES-Rae-1-IL-21. In the
process, GM-CSF-GFP was used for MCS A and Rae-1-
IL-21 was used for MCS B.A mouse model of subcutaneous liver cancer
The hepatic cancer cell-line H22 was adoptively trans-
ferred into mice to construct a mouse model of sub-
cutaneous liver cancer. The mice were sacrificed to
harvest their tumor tissues. Fresh tumors with vigorous
growth were selected and prepared as a tumor single-
cell suspension (at a density of 6 × 107 cells mL-1). The
suspension (50 μL) was injected into the armpit of the
right forelimb of experimental mice using a 1 mL
syringe.Table 1 Showing the primer sequences used to amplify










Note: Italics indicates the enzyme cleavage sites for XhoI and EcoRI, EcoRI and
MluI, Xba1and Sal1, and Sal1and Not1.Recombinant plasmid treatment in a mouse model of
subcutaneous liver cancer
On the 5th day after the mouse model was established,
mice were randomly divided into six groups of 10 mice
per group including control, IRES/GFP, IRES/IL-21,
IRES/GM-SCF, IRES/GM-SCF-IL-21 and IRES/combin-
ation. In the control group, mice were injected with
200 μL phosphate buffered saline (PBS). Additionally,
200 μL PBS containing 100 μg of the recombinant plas-
mid was injected to the mouse tumors of each group
(IRES/GF, IRES/IL-21, IRES/GM-SCF, IRES/GM-SCF-IL-
21 and IRES/combination). The injection was repeated
once a day for five continuous days. After ten days, the
mice in each group were sacrificed by overdosing of the
anesthesic agents. The liver cancer tissues of each mouse
in each group were separated from the mouse by a con-
ventional technique and made into specimens suitable
for determination of their weights and volumes. Tumor
volumes were calculated by the formula: Tumor volume
(cm3) = 0.523 × L ×W2. Here, L (cm) and W (cm) indi-
cated the length and width of the tumors respectively as
measured by a Vernier caliper. Gene and protein expres-
sion of GFP, Rae-1, GM-SCF and IL-21 were then de-
tected in the tumor tissues by RT-PCR and Western blot
analysis of each group. The remaining experimental
models of 13 mice per group were used for survival
analysis.
ELISA detection of IL-2 and INF-γ
Mouse serum specimens were isolated in each group
and kept at −20°C for determination of IL-2 and INF-γ
content. For ELISA detection, serum specimens were
thawed at 37°C in an incubator, followed by dilution
with double distilled water to 500 μL. Meanwhile, the
IL-2 and INF-γ standards were diluted to 8000 μg L-1. In
a 96-well microtiter plate, each well then received
150 μL diluted specimens, and then 50 μL standards or
specimens were added for 15 min. They were oscillated
evenly and incubated for 2 h at room temperature. The
liquid in the wells was removed and the wells washed
with 400 μL of detergent-containing buffer four times,
followed by the addition of horseradish peroxidase-
conjugated IL-2 and INF-γ (200 μL), then oscillated
evenly, and incubated for 2 h at room temperature.
Next, the liquid was removed and washed with 400 μL
detergent-containing bugger four times. An equal
amount of developer A and B were evenly mixed, which
were added with 200 μL of the enzyme labeled antibody,
and then incubated at room temperature in the dark for
30 min. Next, 50 μL of stop buffer was added to com-
plete the enzyme reaction. The specimens were immedi-
ately detected using spectrophotometry by measuring its
optical density at a wavelength of 450 nm. Samples and
standards were run in triplicate, and the sensitivity of
Cheng et al. Molecular Cancer 2013, 12:166 Page 4 of 14
http://www.molecular-cancer.com/content/12/1/166the assays was determined to be 0.1 units/mL for both
IL-2 and INF-γ.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total cellular RNA was determined by the Trizol
method. The reverse transcription was conducted using
1 μL RNA and 0.5 μL AMV reverse transcriptase, 2.5 μL
cDNA as a template for PCR amplification, 0.1 μL poly-
merase Ex Taq HS, 0.1 μL sense primer and 0.1 μL anti-
sense primer. The reaction conditions were: 94°C initial
denaturation for 2 min, 94°C denaturation for 40 s, 50-
65°C annealing for 40 s, 72°C extension for 1 min, and a
total of 35 cycles, and 72°C extension for 5 min for one
cycle. The PCR products were kept frozen at −20°C. The
glyceraldehyde-phosphate dehydrogenase (GAPDH) gene
was used as an internal housekeeping control and ampli-
fied as described above. The shRNA target fragments and
6 μL of the PCR products of the internal control GAPDH
were separated on a 2% agarose gel and by electrophoresis
at 120 V and 100 mA for 30 min. After electrophoresis,
the gel was placed in ethidium bromide (EB) staining solu-
tion for 5 min. The positive PCR reactions showed clear
amplification segments as expected. Quantity-One soft-
ware (Bio-Rad Laboratories Inc, Hercules, CA, USA) was
used for analysis of electrophoresis data, and gray-scale
scanning. By comparison against the gray values of
GAPDH, we obtained relative values of the mRNA prod-
ucts in the sample target genes.
Western blot analysis of relative protein expression
The extraction was performed in order to harvest suffi-
cient proteins for 12% w/v sodium lauryl sulfate polyacryl-
amide gel electrophoresis (SDS-PAGE). Before placing
samples on the separating gel, proteins underwent electro-
phoresis at 80 V and then at 120 V until its front was
about 1 cm from the bottom of the gel. Polyvinylidene
fluoride fibre (PVDF) membranes were immersed in
methanol for 5 min, then transferred to a buffer solution
(pH 8.3, 25 mmol L-1 Tris–HCl, 192 mmol L-1 glycine,
and 20% methanol) for 10 min at room temperature. Pro-
teins were transferred onto PVDF membranes at 100 V
for 70 min, and then blocked with 5% bovine serum albu-
min/PBS by incubating the membrane overnight at 4°C,
and then reacting the membrane with diluted primary
antibodies (1:2000) for 3 min at room temperature,
rinsing in 0.05% PBS-Tween 20 three times for 10 min
each. Membranes were then reacted with diluted sec-
ondary antibodies (1:8000) for 3 h targeted against the
membrane-bound protein-primary antibody complexes
with rinsing in 0.05% PBS-Tween 20 three times for
10 min each, followed by detection in ECL reagent. Equal
parts of solutions A and B in the ECL kit were mixed, and
reacted with the membrane for 1 min. Proteins were de-
veloped and photographed by a gel imaging system. Thefilm scanning of the protein was performed using an
Image J version 1.44 software program to obtain average
density values (ADV). The relative absorbance value was
calculated as a ratio of ADV and GAPDA.
Flow cytometry
Mice spleens were harvested, carefully ground, and filtered
against mesh screens to obtain single-cell suspensions,
which were incubated in RPMI 1640. Cells were seeded
into a 96-well microtiter plate, followed by centrifugation
at 300 g for 5 min. Then, cell pellets were retained and
washed 2–3 times with 200 μL of PBS. The washed cells
were mixed with a blocking agent and incubated under
gentle shaking at 4°C for 60 min, followed by washing
2–3 times with 200 μL of PBS. Diluted antibodies (anti-
CD3, anti-CD4, anti-CD8, anti-CD25, anti-CD19, anti-
CD11b, anti-CD27 and anti-Foxp3 antibodies) were
added to their respective wells, incubated at 4°C under
gentle shaking for 60 min, and washed 2–3 times with
200 μL of PBS. Then, cells were resuspended in 200 μL
of cold PBS and kept in the dark for determination of
the total numbers of CD3+ T cells, Th cells of the CD3+
CD4+ phenotype, CTL cells of the CD3+ CD8+ pheno-
type, B cells of the CD3- CD19+ phenotype, NK cells of
the CD11b+ CD27+ phenotype, and Treg cells expressing
CD4+ CD25+ Foxp3+ by flow cytometry (BD Biosciences,
Franklin Lake, NJ, USA).
MTT detection of CTL and NK activity
Using the random number method, three mice models
were detected by MTT in each group. Spleen cells (NK
and CTL cells) were enumerated by flow cytometry.
Their densities were then adjusted to 1×106/mL. YAC-1
and H22 were used as target cells for NK and CTL re-
activity, respectively. Cells were incubated in RPMI 1640
containing 10% fetal bovine serum at 37°C in an atmos-
phere of 5% CO2 in air for 48 h. Cell density was
adjusted to 1 × 105/mL. Three mice were randomly se-
lected in each group for detection of CTL and NK cell
activity. One hundred μL of spleen and target cells (at
an effector:target cell ratio of 10:1) were added to a 96-
well staining plate. After 18 h of incubation, MTT
(20 μL) was added to each well and incubated for an
additional 4 h. After centrifugation, the supernatant was
removed, and dimethyl sulfoxide (DMSO) (200 μL) was
added and agitated for 20 min. Absorbance was deter-
mined at a wavelength of 570 nm (A570). The activity of
CTL and NK cells were calculated as follows:
Activity ¼ ð1− A570of effector−target cells−A570of effector cellsð Þ
=A570of target cellsÞ  100%
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microscopy
NK cells and CTL were detected by flow cytometry ac-
cording to the method described above. NK cells or
CTL were permitted to attach to the coverslips in 6-well
plates, following which, the medium was removed, the
plates were rinsed twice with PBS, and 2 mL 4% parafor-
maldehyde was added to each well. Plates were incu-
bated at room temperature for 20 min, rinsed with 2 mL
PBS three times for 5 min every time. Cells were perme-
abilized with 2 mL 0.1% Triton X-100 in phosphate buff-
ered saline solution at 4°C for 10 min, aspirated, and
cells were rinsed in PBS for 5 min at room temperature.
Next, non-specific interactions were blocked with 4%
bovine serum albumin in phosphate buffered saline solu-
tion at 37°C for 30 min, and primary antibody solution
was added and incubated at 4°C overnight. The primary
antibody solution was removed, washed in PBS for
5 min, add secondary antibody solution was added to
the cells and incubated at room temperature for 1 hr.
Cells were washed in PBS three times for 5 min each,
following which anti-fade DAPI solution was added if
needed. Finally NK cells or CTL were observed by fluor-
escence microscopy.
Data analysis
All data were expressed as mean ± standard deviation
(SD). One-way analysis of variance (ANOVA) and the
least significance difference (LSD) test were used forFigure 1 Design and construction of the new expression vector pGM-
immune escape inhibitory system; B: the map of the pIRES expression vectinter-group comparisons of the data. Kaplan-Meier sur-
vival plots were used for calculation of survival data. For
all analyses, a probability less than an alpha value of 0.05
(P < 0.05) were considered significantly different among
groups.
Results
Identification of the new vector pGM-CSF-GFP-IRES-Rae-1-
IL-21
According to the pIRES vector map (Figure 1A-B), the
genes of GFP, IL-21, GM-CSF and Rae-1 were built into
the empty plasmid and the new vector pGM-CSF-GFP-
IRES-Rae-1-IL-21 was constructed. The positive clones
were selected by restriction endonuclease, and the pre-
cise clones were confirmed by DNA sequence analyses
and end-use sequences. The band of the GFP product
(720 bp) was obtained by cutting pGM-CSF-GFP-IRES-
Rae-1-IL-21 by EcoRI and MluI, and had the same size as
the target gene. Likewise, the band of the GM-CSF prod-
uct (425 bp) was obtained by cutting pGM-CSF-GFP-
IRES-Rae-1-IL-21 by XhoI and EcoRI, and had the same
size as the target gene. The band of Rae-1 (1106 bp) that
was obtained by cutting pGM-CSF-GFP-IRES-Rae-1-IL-
21 with Xba1 and Sal1 had the same size as the target
gene. The band of the IL-21 (441 bp) product was ob-
tained by cutting pGM-CSF- GFP-IRES-Rae-1-IL-21 by
Sal1and Not1, and had the same size as the IL-21 target
gene. The obtained genes of GFP, GM-CSF, Rae-1, and
IL-21 were identical with the original sequences as definedCSF-GFP- IRES-Rae-1-IL-21. A: Design and construction of the
or.
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cessfully constructed (DNA sequence analysis data not
shown).
Inhibitory effect of pGM-CSF-GFP-IRES-Rae-1-IL-21 on
mouse liver cancer
After 10 days of treatment, mice in each group were
sacrificed by overdosing of anesthesia and mice were
then routinely dissected for their livers cancer specimens.
The histological analyses were performed on the tumor
sites, and revealed that the IRES/combination group were
infiltrated by massive numbers of monocytes and neutro-
phils, the tumors had obviously shrunk, experienced or-
dered rarefaction, and had degenerated (Figure 2A(f)). In
the IRES/GM- SCF-IL-21 group, infiltration of immuno-
cytes had increased appreciably and necrotic tumor cells
were noticeable in the tumor tissue (Figure 2A(e)). In the
IRES/GM-SCF or IRES/IL-21 group the tumor cells grew
slowly, and there were few immunocytes infiltrating the
tumor tissues (Figure 2A(c-d)). By contrast, the active
growth of the tumor cells, and obvious nuclear division or
diverse nucleic type, was found in both the control and
the IRES/GFP groups (Figure 2A(a-b)).
Histological analyses suggested that the GM-SCF, IL-21,
and Rae-1 genes alone or in combination induced a cellu-
lar immune response against H22 tumor cells. The speci-
mens were weighed and the results described (Figure 2B).
The tumor weight averaged 0.207, 0.522, 0.873, 0.843,
1.439, and 1.591 g for IRES/combination, IRES/GM-SCF-
IL-21, IRES/GM-SCF, IRES/IL-21, IRES/GFP, and the con-
trol group, respectively, which were significantly different
(P < 0.01). The tumor was also significantly (P < 0.01) ligh-
ter in the IRES/GM-SCF-IL-21 group than was found in
either the IRES/GM-SCF or IRES/IL-21 groups and was
not significantly different (P > 0.05) between either the
IRES/GM-SCF group or the IRES/IL-21 group.
The tumor was significantly heavier in the control group
and lightest in the IRES/combination among the six
groups (P < 0.05). By 1–5 days after treatment, the tumor
volume had gradually increased in all groups (Figure 2C).
After 6 days, the tumor volume had gradually decreased
in the IRES/combination group, and was marginally sup-
pressed in the IRES/GM-SCF-IL-21, IRES/GM-SCF, and
IRES/IL-21 groups, but had increased rapidly in both the
IRES/GFP and control groups. At the conclusion of treat-
ments, tumors were significantly smaller (P < 0.01) in the
IRES/GM-SCF-IL-21 group than was found in either the
IRES/GM-SCF or IRES/IL-21 groups but this was not sig-
nificantly different (P > 0.05). The tumor volume of the
mice was highest in both the IRES/GFP group and the
control group (P < 0.01) and smallest in the IRES/combin-
ation group (P < 0.01).
The mice models of subcutaneous liver cancer were
randomly divided into six groups with 13 mice in eachgroup and were treated with the procedure described
above to record their survival rates by the Kaplan-Meier
survival method. Mouse survival was found to decline,
with the first deaths seen at 6, 5, 17, 15, and 21 days
after treatment in the control, IRES/GFP, IRES/GM-SCF,
IRES/IL-21, and IRES/GM-SCF-IL-21 groups respect-
ively (Figure 2D). All mice had demised by 14 and
16 days after treatment in the control and IRES/GFP
groups, respectively. There were 2, 1, and 11 mice sur-
viving 60 days after treatment in the IRES/GM-SCF,
IRES/IL-21, and IRES/GM-SCF-IL-21 groups respectively.
The survival rates of mice were 73.33%, 13.33%, and
6.67% at 60 days of treatment for groups IRES/GM-SCF-
IL-21, IRES/GM-SCF and IRES/IL-21, respectively. The
survival rate of the mice was significantly higher in the
IRES/GM-SCF-IL-21 than was found in the other groups.
Effect of pGM-CSF-GFP-IRES-Rae-1-IL-21 on IL-2 and INF-γ
levels
The levels of IL-2 and INF-γ of mice 1–6 days after
treatment gradually increased in the IRES/combination
groups, including IRES/GM-SCF-IL-21, IRES/GM-SCF
and IRES/IL-21 (Figure 3A-B). They were highest in the
IRES/combination group and lowest (P < 0.01) in the
IRES/GM-SCF and IRES/IL-21 groups, with the IRES/
GM-SCF-IL-21 group showing intermediate levels. By
6–10 days after treatment, IL-2 and INF-γ levels had stably
increased in the IRES/combination groups, but had grad-
ually decreased in the IRES/GM-SCF-IL-21, IRES/GM-SCF
and IRES/IL-21 groups. At the end of treatment, IL-2 and
INF-γ levels were significantly higher in the IRES/GM-
SCF-IL-21 group than were found in either the IRES/GM-
SCF group or IRES/IL-21 group (P < 0.01), which were
also significantly higher than either the IRES/GFP or con-
trol groups (P < 0.01). The levels of IL-2 and INF-γ were
highest in the IRES/combination group (P < 0.01) and not
significantly (P > 0.05) different among the IRES/GM-SCF,
IRES/IL-21, IRES/GFP, and control groups. By 1–10 days
after treatment, IL-2 and INF-γ levels remained unaltered
in the IRES/GFP and control groups.
Effect of pGM-CSF-GFP-IRES-Rae-1-IL-21 on expression of
Rae-1 and protein in liver cancer tissue
RT-PCR and Western blot assays were used to detect
liver cancer tissues and to analyze the effect of GFP,
GM-SCF, IL-21 and Rae-1 constructs and protein expres-
sion in liver cancer tissue. The genes and protein expres-
sions of GM-SCF in IRES/GM-SCF, IRES/GM-SCF- IL21
and the IRES/combination group were significantly en-
hanced (Figure 3C-D). Similarly, the expression of IL-21
in IRES/IL21, IRES/GM-SCF-IL21 and IRES/combination
groups were significantly increased (Figure 3C-D). More-
over, Rae-1 mRNA and protein expression in the IRES/
combination group was the highest, and the gene and
Figure 2 Inhibitory effects of different expression plasmids on liver cancer in a mouse model. The differential plasmid treatments were:
Control, pGFP-IRES, pGM-CSF-IRES, pIL-21-IRES, pGM-CSF-IRES-IL-21, and pGM-CSF-GFP-IRES-Rae-1-IL-21. Tumor-bearing mice were sacrificed 10 d
after treatment and histological sections were made from various tumor tissues. A; Histopathology of tumor tissues in mouse liver cancer
(HE × 400 magnification). (a) and (b) shows histopathological tumor tissue sections in mice treated with PBS or pGFP-IRES, wherein the tumor cells
grew actively. (c) and (d) shows histopathological sections from the tumor tissue of tumor-bearing mice treated with pGM-CSF-IRES or pIL-21-IRES,
wherein the tumor cells grew slowly, and only few immunocytes were seen infiltrating the tumor tissue. (e) showing histopathological sections from
the tumor tissues of tumor-bearing mice treated with pGM-CSF-IRES-IL-21. Infiltration of immunocytes increased appreciably and necrotic tumor
cells were noticeable in the tumor tissue. (f) showing histopathological sections of the tumor tissues in tumor-bearing mice treated with
pGM-CSF-GFP-IRES-Rae-1-IL-21. Here, both monocytes and neutrophils infiltrated the tumor, and there was evidence of mass necrosis seen in
the tumor tissue. Note that the red arrow indicates inflammatory cells. B; showing the tumor weights (expressed as mean ± standard deviation)
of mice in each group 10 d after treatment (n = 10). C; tumor volumes of mice (expressed as mean ± standard deviation) in each group 1–10 d
after treatment (n = 10). D; showing the survival time of the mice in each group (n = 13) that were analyzed by the Kaplan-Meier approach.
Note: **P < 0.01, as compared with the control. ##P < 0.01, as compared with the IRES/GM-SCF or IRES/IL21 expression constructs. △P < 0.05, as
compared with the IRES/GM-SCF-IL-21 expression construct.
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Figure 3 IL-2 and INF-γ levels in mouse serum and expression of GPF, GM-SCF, IL-21 and Rae-1 in liver cancer tissue in each treatment
group. Effect of the plasmids on IL-2 and INF-γ levels in mouse serum of each group that included: control, pGFP-IRES, pGM-CSF-IRES, pIL21-IRES,
pGM-CSF-IRES-IL21, and pGM-CSF-GFP-IRES-Rae-1-IL-21. At 10d after treatment, mouse serum was quantified by ELISA for IL-2 levels and INF-γ
levels. Tumor tissue was assessed by RT-PCR and Western blot to determine GPF, GM-SCF, IL-21 and Rae-1 expression. A: IL-2 levels were detected
and expressed as mean ± standard deviation (n = 3); B: INF-γ levels were tested by ELISA and expressed as mean ± standard deviation (n = 3);
C: RT-PCR analysis of GPF, GM-SCF, IL-21 and Rae-1 in liver cancer tissue (n = 3). D: Western blot analysis of GPF, GM-SCF, IL-21 and Rae-1 in liver
cancer tissue (n = 3). D: Western blot analysis of GPF, GM-SCF, IL-21 and Rae-1 in liver cancer tissue (n = 3). E: relative values of Rae-1 protein or
mRNA expression in liver cancer tissue of each group, expressed as mean ± standard deviation (n = 3). Note: Lane 1, control. Lane 2, pIRES/GFP.
Lane 3, pIRES/IL2. Lane 4, pIRES/GM-SCF. Lane 5, pIRES/GM-SCF-IL21. Lane 6, pIRES/combination. * P < 0.05 and ** P < 0.01, as compared with
control. # P < 0.05 and ## P < 0.01, as compared with IRES/GM-SCF and IRES/IL21. △ P < 0.05 and △△ P < 0.01, as compared with IRES/GM-SCF-IL21.
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http://www.molecular-cancer.com/content/12/1/166protein expression of GFP were markedly higher in the
IRES/GFP and IRES/combination group. These observa-
tions informed us that the recombinant plasmids were
successful constructed and transfected in vivo and were
stably expressed. Expression of Rae-1 and protein were
significantly (P < 0.01) different among the six groups
(Figure 3C-E). Rae-1 was also significantly (P < 0.01)
higher in the IRES/combination group as compared
with the IRES/GM-SCF-IL-21, IRES/IL-21, or IRES/
GM-SCF groups, and was significantly (P < 0.01) higher
in the IRES/GM-SCF-IL-21 group as compared with the
IRES/IL-21 or IRES/GM-SCF groups. Rae-1 expression
was also significantly (P < 0.01) higher in the IRES/IL-21
or IRES/GM-SCF groups than in the IRES/GFP and
control groups. However, expression of Rae-1 was not
significantly (P > 0.05) different between the IRES/IL-21
and IRES/GM-SCF groups, or when compared with
either the IRES/GFP and control groups.
Effect of pGM-CSF-GFP-IRES-Rae-1-IL-21 on the frequencies
of NK and CTL cells, cellular cytotoxicity and Treg ratios in
mouse spleen
In order to study the putative mechanisms responsible
for the inhibitory effects of the pGM-CSF-GFP-IRES-Rae-1-IL-21 construct on liver cancer tumors, we mea-
sured spleen cell frequencies by flow cytometry and MTT
assays. We determined that the proportion of CD3-CD19+,
CD3+CD4+ and CD3+ cells in mouse spleen were not
significantly (P > 0.05) different before or after treatment
(Figure 4D). The proportion and cytotoxicities of both NK
and CTL cells were significantly (P < 0.01) different among
the six groups (see Figure 4A-B, and Table 2). When com-
pared with the control group, the frequency and cytotox-
icity of NK and CTL cells were significantly (P < 0.01)
increased in the IRES/combination, IRES/GM-SCF-IL-21,
IRES/IL-21, and IRES/GM-SCF groups, especially in re-
spect of the IRES/combination. The proportion and cyto-
toxicity of NK and CTL cells were significantly (P < 0.01)
higher in the IRES/GM-SCF or IRES/GM-SCF-IL-21
groups than in the IRES/IL-21 group. There was no sig-
nificant (P > 0.05) difference between either the control or
the IRES/GFP group, or between the IRES/IL-21 and
IRES/GM-SCF groups. The CTL and NK cells showed
green fluorescence in the IRES/combination and IRES/
GFP group (Figure 5), and the fluorescence intensity of
both CTL and NK cells in the IRES/combination group
was significantly stronger as compared with the IRES/GFP
group. In addition, there was no green fluorescence in
Figure 4 Effect of the plasmids on NK, CTL and regulatory T cell (Treg) frequencies in mice. Plasmids included: control, pGFP-IRES,
pGM-CSF-IRES, pIL-21-IRES, pGM-CSF-IRES- IL-21, and pGM-CSF-GFP-IRES-Rae-1-IL-21. At 10 d after treatment, mice were sacrificed and flow cytometry
was used to determine splenic total T cells CD3+, Th cells (CD3+ CD4+), CTL (CD3+ CD8+), B cells (CD3-CD19+), NK cells (CD11b + CD27+) and the
proportion of Treg cells (CD4+ CD25+ Foxp3+). A: flow chart and frequency of NK, and B: flow chart and frequency of CTL in a mixed population of
spleen cells. C: flow chart and frequency of Treg cells from the same tissue. D: ratios of T cells (CD3+), Th cells (CD3+ CD4+), and B cells (CD3-CD19+)
in the spleen after 10 d of treatment. E: NK and CTL-mediated cytotoxity as determined by MTT assays after 10 d of treatment. All data were expressed
as mean ± standard deviation (n = 3). Note: *P < 0.05 and **P < 0.01, as compared with control. #P < 0.05 and ##P < 0.01, as compared with IRES/GM-SCF
and IRES/IL-21. △P < 0.05 and △△P < 0.01, as compared with IRES/GM-SCF-IL-21.
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Table 2 The raw data showing the frequency of NK, CTL and Treg cells in each group (n = 3)
Group CD11b + CD27 + (%) CD3 + CD8 + (%) CD4 + CD25 + Foxp3 + (%)









































2.08 ± 0.116.25 21.37 2.05
6.37 21.28 1.98
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http://www.molecular-cancer.com/content/12/1/166other groups because they lacked the GFP gene. These ob-
servations further confirmed the effect of NK and CTL
cells against targeted tumor cells.
At the end of treatment, the frequencies of Tregs were
significantly different among groups (Figure 4C and
Table 2). When compared with control, Tregs were signifi-
cantly (P < 0.01) fewer in number in the IRES/combination
groups, IRES/ GM-SCF-IL-21, IRES/IL-21 and IRES/GM-
SCF groups. Tregs were also significantly (P < 0.01) lower
in the IRES/GM-SCF- IL-21 group than in either the
IRES/IL-21 or the IRES/GM-SCF groups. No significant
(P > 0.05) difference was found between either the IRES/
IL-21 group or the IRES/GM-SCF group, or between the
control and IRES/GFP groups. These observations indi-
cated that pGM-CSF-GFP-IRES-Rae-1-IL-21 significantly
inhibited the growth of liver tumors by lowering the Treg
frequency, increasing immune modulation, frequency and
cytotoxic activities of immune cells like CTL and NK cells,
enhancing Rae-1 expression in liver cancer tissues, and fa-
cilitating the recognition of tumor cells by CTL and NK
cells and debulking liver cancer.
Discussion
The development of tumors is related to the relative com-
petence of host immunity [16]. As with other tumors, liver
cancer induces a relative state of immune suppression
or dampening of host immunity, and a change in themolecular expression of surface markers by cancer cells
that permits the escape of tumor cells from immune rec-
ognition [17] by such cells as NK and CTL cells. Mean-
while, in tumor cells that are recognized by CTL and NK
cells (e.g., MHC-1 ligand and Rae-1) obviously decrease
or disappear, and liver cancer cells survive in the host
[18,19]. Current studies on the treatment of tumors by
GM-SCF or IL-21 mostly focus on enhancing CTL and
NK cell-mediated activity [20,21] or increasing genes that
can be expressed by tumors and recognized by NK and
CTL cells in tumor tissues [22]. Such strategies rarely en-
deavor to simultaneously increase cell-mediated activity or
genes that are recognized by NK and CTL cells in tumors.
In this study, we successfully constructed an immune
escape inhibition system (Figure 1A), which was afforded
by the construction of the recombinant expression plasmid
pGM-CSF-GFP-IRES- Rae-1-IL-21 that passed RT-PCR
and gene sequencing analyses to augment host immunity
and proteins that are expressed by tumor cells and then
recognized by host immune cells. The recombinant plasmid
(IRES/combination) used in this mouse model of subcuta-
neous liver cancer resulted in decreased tumor weights as
compared mice that were transfected with IRES/GM-SCF-
IL-21, IRES/GM-SCF and IRES/IL-21 treatment alone. In
the IRES/combination transfected animals, the tumor vol-
ume was the least by the end of treatment. By 1–5 d after
treatment, the tumor volume in each group gradually in-
creased, which might be related to a weak inhibition of
Figure 5 CTL and NK cells were observed by fluorescence microscopy (n = 3). 10 d after treatment, mice spleens were harvested, NK and
CTL cells were elected by flow cytometry. Hepatic cancer cells carried the green fluorescent protein (GFP)-expressing vector, and upon injury by
CTL and NK cells, the carrying GFP gene vectors is released from the cells in hepatic cancer tissues. GFP-expressing NK and CTL cells were
observed by scanning with a fluorescence microscope (× 200 magnification). The right panel represents the phase contrast images of transfected
CTL and NK cells that expressed the GFP-fluorescent marker.
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of treatment. By 6–10 d after treatment, the tumor
volume in the IRES/combination group was decreased,
which might be associated with a potent anti-tumor
effect caused by high expression of the target genes. In
the other groups, the tumor volume increased at a
much lower rate or even decreased. This observation
indicated an inhibitory effect of these genes on tumorsize. Among the groups, the anti-tumor inhibitory effect
of the IRES/combination was highest and tumor cell
necrosis, monocyte- and neotrophilic-infiltration were
more obvious in the tumor tissues (Figure 2A(f)). We also
found that the survival rates of mice were highest in the
IRES/combination group, which indicated that recom-
binant genes of GM-SCF, IL-21, and Rae-1 displayed the
most effective treatment against liver cancer.
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immune cells. Cytokines have potent immune-regulating
effects, and play important roles in tumor immunity
[23,24]. GM-SCF and IL-21 augment expression of INF-γ
and IL-2, improve the activity of CTL and NK cells, and
inhibit growth of tumors [25,26]. Our study showed that
levels of both INF-γ and IL-2 in mice treated with recom-
binant GM-CSF, IL-21 and Rae-1 gene expression vectors
were highly expressed and negatively associated with the
tumor volumes seen in tumor-bearing mice. The numbers
and activity of CTL an NK cells in the IRES/combination
groups were higher than was seen in the IRES/GM-SCF-
IL-21, IRES/GM-SCF, and IRES/IL-21 groups, indicating
that the GM-SCF, IL-21 and Rae-1 genes had a synergistic
effect in promoting secretion of INF-γ and IL-2 levels,
and the numbers and activity of CTL and NK cells. INF-γ
is secreted by CTL and NK cells and belongs to the glyco-
protein family. INF-γ displays potent anti-viral effects, and
is involved in immune regulation, has anti-proliferative ef-
fects, displays other biological characteristics [27,28] and
directly inhibits tumor cells. INF-γ displays immuno-
regulatory effects and activates enhanced phagocytic func-
tions of both mononuclear macrophages and NK cells.
INF-γ also enhances the differentiation and maturation of
B and T cells, increases the cytotoxic activity of CTL cells,
induces the expression of MHC-I antigens by tumor cells,
and increases the recognition of tumors by immune cells
such as CTL and NK cells [29].
The cytokine IL-2 is a growth factor of T cells, and is
important in the activation and proliferation of T cells,
activates B cells and macrophages, and activates T cells
to secrete IL-2 [30]. Therefore, in this study, the com-
bination of GM-SCF, IL-21 and Rae-1 collectively acti-
vated the murine immune system in liver cancer, and
increased the numbers and cytotoxic activities of NK
and CTL cells. Activated CTL and NK cells secreted
INF-γ, and high INF-γ levels enhanced the numbers and
cytotoxic activities of NK and CTL cells. Likewise, the
release of IL-2 promoted significant activation of CTL in
an autocatalytic immunological cycle that finally inhib-
ited tumor growth.
We found that the expression of Rae-1 and protein
was significantly higher in the IRES/combination group
as compared with the other groups, and that GM-SCF
and IL-21 stimulated the expression of the Rae-1 gene.
Most NK and CTL cells express the Rae-1 receptor,
which easily combines with Rae-1 that is expressed by
liver cancer tissues to enhance the removal of cancer tis-
sue by NK cells and CTL [31]. Our study showed that
pGM-CSF-IL-21-Rae-1 increased the number and cyto-
toxicity of CTL and NK cells, and enhanced the expres-
sion of Rae-1 in liver cancer tissues. Therefore, CTL and
NK cells that expressed the Rae-1 receptor efficiently
eliminated Rae-1.Tregs belong to a subgroup of T cells that are of spe-
cial immune regulatory importance, and are important
in tumor immunity. Foxp3 is a special transcription fac-
tor expressed by Tregs and it is essential for their devel-
opment and function [32]. First, as with other tumors,
liver cancer causes an increase in the frequency of Tregs
and immune inhibition by non-specific suppression of
major histocompatibility complex (MHC), and second
it causes specific suppression. In the first mechanism,
there is broad inhibition of immunity including effects
on dentritic cells, NK cells, macrophages, and CD4+ and
CD8+ T cell sub-populations [33,34]. In specific suppres-
sion, Treg is of special T cell receptor immune complex
(TCR) importance and displays specific MHC restriction.
Thus, antigens related to specific tumors activate Tregs.
Active Tregs inhibit activation of CD4+, CD8+ T cells
and B cells, which can finally result in the resistance of
immune cells to tumor antigens [35]. In this study, we
treated liver cancer with a recombinant plasmid of GM-
SCF, IL-21 and Rae-1 and found that the frequency of
Tregs was significantly decreased as compared with treat-
ment using a single gene. This observation indicated that
the recombinant plasmid played a synergistic effect on the
decrease in Treg frequencies. It was previously reported
that IL-21 enhances activation and cytotoxicity of CTL
and NK cells, and alleviates immune inhibition of Tregs
[36,37]. As an anti-apoptotic cytokine, IL-21 can sustain
survival of active T cells [36,37]. Tian Yongju [38] found
that IL-21 decreases Treg frequencies and apoptosis of
peripheral blood mononuclear cells (PBMC), and greatly
increases the cytotoxicity of PBMC, which can be allevi-
ated by IL-21 antibodies. However, thus far, little informa-
tion has detailed the effects of GM-SCF and Rae-1 gene
expression on Treg frequencies in a mouse tumor model.
Here, we have attempted to confirm that IL-21 decreased
the frequency of Tregs. Further, this effect was promoted
by expression of GM-SCF and Rae-1. The mechanisms
involved in this effect require further study.
Conclusion
In summary, GM-SCF, IL-21 and Rae-1 greatly inhibited
the growth of liver cancer in a relevant mouse model.
The mechanisms responsible for this inhibitory effect
might be related to the activation of host cell-mediated
immunity that was induced by the triple gene expression
vector. We also propose that this might have increased
the numbers and cytotoxicity of NK and CTL cells, low-
ered Treg frequency, and alleviated any inhibition of
CTL and NK cells. Active CTL and NK cells increased
their ability to secrete INF-γ that augments activation
and cytotoxicity of NK and CTL cells. Similarly, active
CTLs increased their ability to secrete IL-2 that can
drive activation and cytotoxicity of CTL. In an autocata-
lytic cascade of cell-mediated immunity and immune
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http://www.molecular-cancer.com/content/12/1/166pathways, the recombinant triple-gene expression plasmid
increased Rae-1 expression in cancer, thus efficiently
eliminating this tumor by the combined activities of CTL
and NK cells that express cell membrane-associated Rae-1
receptors.
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